The Intestinal Function in People With Prader-Willi Syndrome

January 31, 2012 updated by: Louise Kuhlmann Frandsen, Aarhus University Hospital
The projects aim is to investigate the intestinal function of patients suffering from Prader-Willi Syndrome. The methods used are ultrasonographic measurement of the rectal diameter and gastrointestinal transit time

Study Overview

Status

Completed

Detailed Description

Prader-Willi Syndrome (PWS) is a congenital genetical disease characterized by moderate retardation, food-seeking behavior and a serious risk of developing health threatening overweight, low stature, abnormal body composition and a lack of growth- and sex-hormones. They can not live an independent life and are reliant of help from care personnel.

People with PWS react abnormally to signals from their own bodies. E.g. they have a reduced sense of pain and can have a lacking urge to urination despite a full bladder. Most of the patients also have a relatively slow pulse, which can be consistent with a dysfunction in the nervous system (the parasympathetic nervous system) which also has large significance for the bladder- and bowel function.

The Intestinal function in people with PWS is a sparse described subject, which has not been systematically examined in scientific context. We therefore want to examine whether the bowel function in people with PWS are different from the bowel function in healthy people.

The subject is elucidated by a medical examination, a questionnaire, a registration of toilet habits, a measurement of the rectal diameter by an ultrasound scan and a measurement of the colonic transit time.

The results will be compared to findings in normal healthy people. Because no normal material exists for rectal diameter measured by ultrasound, we will establish one.

The result of the project will increase our knowledge of possible bowel dysfunctions such as constipation, in people with PWS and can immediately lead to improved care for and optimized treatment of the patients.

Study Type

Observational

Enrollment (Actual)

21

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Aarhus N
      • Aarhus, Aarhus N, Denmark, 8200
        • Centre of Rare Diseases, Pediatric department, Aarhus University Hospital Skejby

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients with Prader-Willi Syndrome

Description

Inclusion Criteria:

  • age above 18
  • >14 days since last antibiotic treatment
  • >14 days since last laxative treatment
  • PWS confirmed genetically

Exclusion Criteria:

  • previous abdominal surgery (except appendectomy or haemorrhoidectomy
  • patient not capable of understanding the information
  • treatment with eltroxin or antipsychotic medication
  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Prader-Willi patients
Control group
Control group for ultrasound scan

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Colonic Transit time
Time Frame: 6 days
Measured ad modum Göteborg
6 days
Rectal diameter
Time Frame: 1 day
measured by ultrasound scan
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Louise K Frandsen, Stud.med, Centre of Rare Diseases, Pediatrics department, Aarhus University Hospital Skejby
  • Study Chair: Stense Farholt, Ph.D, Centre for Rare Diseases, Pediatrics department, Aarhus University Hospital Skejby
  • Study Chair: Klaus Krogh, DMSc, Medical Hepato-gastroenterological department, Aarhus University Hospital, Aarhus Sygehus
  • Study Chair: Iben M Jønsson, Ph.D, Pediatrics department, Aarhus University Hospital Skejby
  • Study Chair: Jens B Froekjaer, PhD, Department of Radiology, Aalborg Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2011

Primary Completion (Actual)

January 1, 2012

Study Completion (Actual)

January 1, 2012

Study Registration Dates

First Submitted

January 30, 2012

First Submitted That Met QC Criteria

January 31, 2012

First Posted (Estimate)

February 1, 2012

Study Record Updates

Last Update Posted (Estimate)

February 1, 2012

Last Update Submitted That Met QC Criteria

January 31, 2012

Last Verified

January 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Constipation

Subscribe